Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
Abstract Background: To evaluate neoadjuvant trabectedin (1.5 mg/m2 24-h i.v. infusion every 3 weeks; three to six cycles) in patients with locally advanced my
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 2012
|
| In: |
Annals of oncology
Year: 2012, Volume: 23, Issue: 3, Pages: 771-776 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdr265 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdr265 Verlag, Volltext: https://academic.oup.com/annonc/article/23/3/771/225542 
|
| Author Notes: | A. Gronchi, B. N. Bui, S. Bonvalot, S. Pilotti, S. Ferrari, P. Hohenberger, R. J. Hohl, G. D. Demetri, A. Le Cesne, P. Lardelli, I. Pérez, A. Nieto, J. C. Tercero, V. Alfaro, E. Tamborini, J. Y. Blay |
| Summary: | Abstract Background: To evaluate neoadjuvant trabectedin (1.5 mg/m2 24-h i.v. infusion every 3 weeks; three to six cycles) in patients with locally advanced my |
|---|---|
| Item Description: | Gesehen am 29.05.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdr265 |